History of SOE Inhalation Technology
The heart of our products is based upon technology originally conceived by the German researcher Jörg Klemm who began developing Singlet Oxygen Energy technology in 1987. He worked with a number of partners in different countries to manufacture and market products that mostly concentrated on inhalation therapy.
Over the years, a number of studies have been performed with products utilising activation chambers (catalysts) designed by Jörg Klemm.
Since 2010, SOE Health Ltd. prioritised the continuation of research into the effects of SOE technology on persons of all ages and states of health. In order to ensure factual accuracy and duplicity, we have entered into co-operations with universities and qualified medical personnel around the world.
We will be adding to the chronological list of events on the right as we publish our results and release new products.
Over the years, a number of studies have been performed with products utilising activation chambers (catalysts) designed by Jörg Klemm.
Since 2010, SOE Health Ltd. prioritised the continuation of research into the effects of SOE technology on persons of all ages and states of health. In order to ensure factual accuracy and duplicity, we have entered into co-operations with universities and qualified medical personnel around the world.
We will be adding to the chronological list of events on the right as we publish our results and release new products.
Evolution
Milestones
1987-2004
Project launch and begin of a cooperation with Tony van der Valk / Valkion.
1989
First 100 singlet oxygen producing machines manufactured.
1994-1997
Cooperation with Merlin / Vitaion.
1995
Heinrich Heine University, Düsseldorf, Germany
Test and certification that patented catalysts designed and manufactured by Jörg Klemm produce singlet oxygen in a gaseous environment.
Fitness Clinic of Helsinki
Report: Some physiological effects of breathing singlet oxygen activated air. An experiment with ergospirometry.
1996
Dr. Dr. sc. D. Cimbal, Germany
Evaluation in relation to the effects of SOE on racehorses.
Dr. Anders Willstedt
Beobachtungen an Patienten mit chronischem Fibromyalgie- syndrom.
1998
Scandlab report 30414
Breathing of singlet oxygen activated air and the effect on blood parameters in healthy individuals.
1999
Tetrum Investment
Report on clinical investigations of Singlet Oxygen Therapy Valkion Unit used in sanitarium practice at Chernobyl zone, Ukraine.
Free Radical Biology and Medicine
Report: Harmful Singlet Oxygen can be helpful.
2000-2007
Cooperation with nes AG (Airnergy). Contrary to recent information published by Airnergy AG, Jörg Klemm has no relationship with Airnergy AG, the products, research or manufacture of components.
2001
Dr. E. Krämer, Troisdorf, Germany
Patient observation related to hypercholesterolemia.
2002
Dr. J. Marrongelle, Schuykill Clinic for Integrative Medicine
Clinical evaluation related to the effects of SOE on Fibromyalgia.
2003
CO'MED
Bericht über eine zweiteilige, kontrollierte Studie mittels Herzraten-Variabilitäts-Messungen (HRV) bezüglich der Wirksamkeit der Airnergy+-Sauerstoff-Therapie.
2004
ZÄN
Concentrated Oxygen and activated air: the physiological effects of two inhalation therapies in comparison.
Die Naturheilkunde No. 2 / 2004
New air therapy sets benchmarks.
das schlafmagazin
Airnergy-Sauerstofftherapie im Test: Auswertung einer Patientenbeobachtung.
2008
Begin of research into improving the existing technology and a cooperation with Links (HK) Ltd. to design new products and optimise manufacture.
2010
Application for new patents filed.
Establishment of SOE Health Ltd. with manufacturing facilities in the UK.
1987-2004
Project launch and begin of a cooperation with Tony van der Valk / Valkion.
1989
First 100 singlet oxygen producing machines manufactured.
1994-1997
Cooperation with Merlin / Vitaion.
1995
Heinrich Heine University, Düsseldorf, Germany
Test and certification that patented catalysts designed and manufactured by Jörg Klemm produce singlet oxygen in a gaseous environment.
Fitness Clinic of Helsinki
Report: Some physiological effects of breathing singlet oxygen activated air. An experiment with ergospirometry.
1996
Dr. Dr. sc. D. Cimbal, Germany
Evaluation in relation to the effects of SOE on racehorses.
Dr. Anders Willstedt
Beobachtungen an Patienten mit chronischem Fibromyalgie- syndrom.
1998
Scandlab report 30414
Breathing of singlet oxygen activated air and the effect on blood parameters in healthy individuals.
1999
Tetrum Investment
Report on clinical investigations of Singlet Oxygen Therapy Valkion Unit used in sanitarium practice at Chernobyl zone, Ukraine.
Free Radical Biology and Medicine
Report: Harmful Singlet Oxygen can be helpful.
2000-2007
Cooperation with nes AG (Airnergy). Contrary to recent information published by Airnergy AG, Jörg Klemm has no relationship with Airnergy AG, the products, research or manufacture of components.
2001
Dr. E. Krämer, Troisdorf, Germany
Patient observation related to hypercholesterolemia.
2002
Dr. J. Marrongelle, Schuykill Clinic for Integrative Medicine
Clinical evaluation related to the effects of SOE on Fibromyalgia.
2003
CO'MED
Bericht über eine zweiteilige, kontrollierte Studie mittels Herzraten-Variabilitäts-Messungen (HRV) bezüglich der Wirksamkeit der Airnergy+-Sauerstoff-Therapie.
2004
ZÄN
Concentrated Oxygen and activated air: the physiological effects of two inhalation therapies in comparison.
Die Naturheilkunde No. 2 / 2004
New air therapy sets benchmarks.
das schlafmagazin
Airnergy-Sauerstofftherapie im Test: Auswertung einer Patientenbeobachtung.
2008
Begin of research into improving the existing technology and a cooperation with Links (HK) Ltd. to design new products and optimise manufacture.
2010
Application for new patents filed.
Establishment of SOE Health Ltd. with manufacturing facilities in the UK.
1987
1989
1990
1995
1998
2005
2008
2010
SOE Health Ltd.
Copyright © SOE Health Ltd. 2011 . All rights reserved. Disclaimer. Privacy policy. Terms of use.